12.01.06
PL Thomas & Company Acquires Patent-Pending Indications
PL Thomas & Company (PLT), Morristown, NJ, has acquired new patent-pending indications for its natural vitamin K2 marketed under the trademark MenaQ7. The role of Natural Vitamin K2 in bone health is well established, and recent research has shown that of the group of K vitamins, only K2 is linked to cardiovascular health. The alliance between PLT, Natto Pharma, Norway, and VitaK BV now allows MenaQ7 to be offered for cardiovascular benefits with proprietary research and U.S. patents pending.
PL Thomas & Company (PLT), Morristown, NJ, has acquired new patent-pending indications for its natural vitamin K2 marketed under the trademark MenaQ7. The role of Natural Vitamin K2 in bone health is well established, and recent research has shown that of the group of K vitamins, only K2 is linked to cardiovascular health. The alliance between PLT, Natto Pharma, Norway, and VitaK BV now allows MenaQ7 to be offered for cardiovascular benefits with proprietary research and U.S. patents pending.